Recently，My stake betting appstake betting appShaanxi Provincial Drug Procurement Center issued the "Notice on Supplementary Price Confirmation of the variety of varieties of primary medical institutions"，Added the variety to the 2012 version of the national basic drug directory for price confirmation。Analysis of Mine.com，The price adjustment this time has not been distinguished according to the manufacturer and quality，The price to be confirmed is from the lowest price。This has greatly reduced the prices of many of them，The original drug of stake sports betting appforeign pharmaceutical companies is particularly amazing。

    The price of 0.25g/chip for the injection of Roche Pharmaceuticals is reduced from 21.2 yuan to 0.6 yuan，Novarty Pharmaceutical 缬 Saisan Capsule 80mg*7 from 39.7 yuan to 13.67 yuan，The price of Boli 75 mg of 75 mg*7 under Sanofi is reduced from 119 yuan to 65.3 yuan。

    June 6，My stake betting appstake betting appShaanxi Provincial Drug Procurement Center issued a public announcement on supplementing the unified procurement of primary medical institutions，stake sports betting appforeign pharmaceutical companies that encounter a large price reduction are not seen。Do not distinguish the manufacturer does not distinguish the quality level. Is this a transitional measure，Or will it become the bidding rules of the future base medicine?

    New basic medicine does not distinguish manufacturers

    Data published by the My stake betting appstake betting appShaanxi Provincial Drug Procurement Center，Comparison of the bidding database of the mesh of the mesh，Drug prices of some stake sports betting appforeign pharmaceutical companies have decreased significantly。

    Entryin sodium sodium 0.25g/branch of the injection of Roche Pharmaceuticals is 0.6 yuan，And the price of the drug in Shaanxi last year was 21.2 yuan，decrease of 97%; Hospira Australia Pty LTD's paclitaxel injection 30mg: 5ml of finals is 92.7 yuan，The price in Hubei in April this year is 1174.43 yuan，decreased by 92%; Novartis Pharmaceutical 缬 缬 缬 缬 80mg*7 shortlisted price is 13.67 yuan，The price of winning in Shaanxi last year was 39.7 yuan，Reduced 65%; Sanofi Boli 75mg*7 Film price is 65.3 yuan，The price of winning in Shaanxi last year was 119.13 yuan，Reduced 47%. How did such an amazing price cut? In the announcement of Shaanxi Pharmaceutical Purchase Center, it is pointed out，Filter varieties If more than 3 companies apply for confirmation，Various varieties with the lowest county -level shortlisted prices are preferred，The varieties applying for low -cost follow -up are based on comprehensive evaluation，Followed in turn。According to this rule，If an enterprise wants to enter the grass -roots medical institution，Drug prices must be reduced to the minimum level of all competitors' declaration prices。

    Data published by the My stake betting appstake betting appShaanxi Provincial Drug Procurement Center can be known，The same product regulations、Dalog -type medicines are not distinguished according to the manufacturer。As can be known from the figure above，Pucin Patrol injection 30mg: 5ml three companies Beijing Shuanglu Pharmaceutical Co., Ltd.、Haikou Pharmaceutical Factory Co., Ltd.、Hospira Australia Pty LTD, the shortlisted price is 92.7 yuan，Strictly priced according to the principle of difference in the difference，In the bidding of Hubei in April，The same product regulations for the same product、The price difference between the winning bids of different manufacturers in dosage forms is huge。

    Do not consider the quality level，Different from the manufacturer's price distinction，The low price is to take，This is very rare in the bidding of medicines around stake sports betting appthe stake betting apppast，But this year is not the first time。April this year，Guangxi formulated the "Purchase Catalog of Basic Drugs in Guangxi"，The rules are also selected for the lowest winning price of the "Catalog of Pharmaceuticals for Medical Institutions in Guangxi County and County in Guangxi County and County above the county or above.。It is worth noting is，Shaanxi and Guangxi are not re -bid，It is just a transitional measure for adding varieties for the basic drug directory of the 2012 version of the country，Whether the bidding of basic medicines in various places will no longer distinguish manufacturers and quality levels，Still unknown。

    Foreign -funded pharmaceutical companies enter the dilemma

    The biggest impact of the Shaanxi plan is undoubtedly a stake sports betting appforeign pharmaceutical company，The original price was pulled to the floor。But if this price is not confirmed，It means that you cannot enter the primary medical institution in Shaanxi Province for sale。

    Roche Pharmaceutical and Hospira Australia Pty LTD with a price reduction of up to 90%or more，Because this price impacts too much on the original price system，Abandoning the grassroots market in Shaanxi has become an inevitable choice。Dested，Due to the tragic bidding of basic drugs，Foreign -funded pharmaceutical companies will most of the time to maintain the price system，Choose to give up the market for basic medicines。But for the 47%price reduction of Bolvi, Sanofi，It is still a price for the market，Become a dilemma choice。

    With the advancement of medical reform，The grass -roots medical market has become the market is accelerating。Primary medical terminal growth rate is much higher than that of hospital terminals and retail terminals，The market size has also continued to expand，According to statistics from the CFDA Southern Medical Economics Research Institute,，In 2011, the grass -roots medical market including county -level hospitals，scale reached 169.9 billion yuan，The overall proportion is 18.7%. The attractiveness of the grass -roots medical market to major multinational pharmaceutical companies is getting greater。2012，Sanofi announced the establishment of a grass -roots Medical stake sports betting appDivision，For the first time in stake sports betting appforeign pharmaceutical companies, the business department of independent development of the county -level medical market，Pioneering grass -roots market determination。Due to the patent expiration of Bolvida，Price reduction does not seem to be completely unacceptable。May last year，Sanofi launched a promotion plan in the United States & mdash; & mdash; reduced the monthly cost of Bolvi from $ 100 to $ 37。In the Chinese market，Is Sanofi also chose to use the price to be exchanged for the grass -roots market?

    According to the statistics of Mihon.com，The domestic clopidogre market is still the & quot; Bolvi & QUOT; and Shin Litai's & quot; Thai & Quot; double oligopoly，In 2011, the share of Boli Vae fell to 73.37%，Taijia rose to 26.63%. Due to the patent expiration of Bolvi，Many companies join the ranks of generic drugs，Since 2012 alone, 8 companies have declared raw materials and 5 companies to declare preparations。Some analysts point out，Clopidogre market competition will become more and more intense in the future，In order to occupy the market in advance，Do not rule out that Sanofi price is reduced in exchange for grass -roots markets。May last year，Sanofi has launched a promotional plan in the United States & mdash; & mdash; reduced the monthly cost of Bolvi from $ 100 to $ 37。

    June 6，My stake betting appstake betting appShaanxi Provincial Drug Procurement Center issued a public announcement on supplementing the unified procurement of primary medical institutions，Shin Litai's Taijia 25mg*20 was shortlisted at 74.6 yuan，Bolvi is no longer a trace，Sanofi finally chose to maintain the price system。

    Domestic pharmaceutical companies are also impacted

    Not just stake sports betting appforeign pharmaceutical companies that are affected by price reductions，Domestic pharmaceutical companies are also impacted。Hengrui Pharmaceutical's injection of Osarin 0.1gl finalists is 182 yuan，The price of winning in Shaanxi last year was 256.12 yuan，Reduced 28.9%; the paclitaxel injection of Shuanglu Pharmaceuticals 30mg: 5ml shortlisted price is 92.7 yuan，The price of winning in Shaanxi last year was 127 yuan，Reduced 27%. Osarie Platinum is Hengrui's key product，In 2011, sales exceeded 500 million yuan，If you accept this price, it will have a great impact on performance。In the end Hengrui also chose to give up。

    Sanofer's abandonment becomes all Xinlitai，Xinlitai'Stake Sports Bettings Taijia will monopolize stake betting appShaanxi Clopidogre market。But it is worth noting that，If the bidding of basic medicines will not distinguish the quality level，Taijia's first imitation advantage is gone，It will face the price competition of other generic drug companies，In Anhui County -level market bidding at the beginning of this year，Henan's new coach Ke has squeezed off Xinlitai at a low price，In this bid，Henan's new handsome clopidogrey products winning price is 46.6 yuan，and Taijia 76.91 yuan，Xinlitai abandoned the bidding of Anhui for the maintenance price system。